CLARO (Clinical and Laboratory Applications of Research in Optometry) Research Group, Department of Optics, Faculty of Sciences, University of Granada, Granada, Spain.
Department of Physical Education and Sport, Faculty of Sports Sciences, University of Granada, Granada, Spain.
Int J Sport Nutr Exerc Metab. 2024 Jun 25;34(5):298-306. doi: 10.1123/ijsnem.2024-0051. Print 2024 Sep 1.
The main objective of this placebo-controlled, triple-blind, balanced crossover study was to assess the acute effects of phenylcapsaicin (PC) intake (2.5 mg) on intraocular pressure (IOP), ocular perfusion pressure (OPP), and heart rate (HR) during a 30-min cycling task performed at 15% of the individual maximal power. Twenty-two healthy young adults performed the cycling task 45 min after ingesting PC or placebo. IOP was measured with a rebound tonometer before exercise, during cycling (every 6 min), and after 5 and 10 min of recovery. OPP was assessed before and after exercise. HR was monitored throughout the cycling task. We found an acute increase of IOP levels related to PC consumption while cycling (mean difference = 1.91 ± 2.24 mmHg; p = .007, ηp2=.30), whereas no differences were observed for OPP levels between the PC and placebo conditions (mean difference = 1.33 ± 8.70 mmHg; p = .608). Mean HR values were higher after PC in comparison with placebo intake (mean difference = 3.11 ± 15.87 bpm, p = .019, ηp2=.24), whereas maximum HR did not differ between both experimental conditions (p = .199). These findings suggest that PC intake before exercise should be avoided when reducing IOP levels is desired (e.g., glaucoma patients or those at risk). Future studies should determine the effects of different ergogenic aids on IOP and OPP levels with other exercise configurations and in the long term.
本安慰剂对照、三盲、平衡交叉研究的主要目的是评估摄入苯甲酰基辣椒素(PC)(2.5mg)对个体最大功率的 15%进行 30 分钟踏车任务期间眼压(IOP)、眼灌注压(OPP)和心率(HR)的急性影响。22 名健康年轻成年人在摄入 PC 或安慰剂后 45 分钟进行踏车任务。在运动前、踏车期间(每 6 分钟一次)以及恢复 5 和 10 分钟后使用回弹眼压计测量 IOP。在运动前后评估 OPP。整个踏车任务期间监测 HR。我们发现与 PC 消耗相关的 IOP 水平在踏车期间急性升高(平均差异=1.91±2.24mmHg;p=.007,ηp2=.30),而 PC 和安慰剂条件之间的 OPP 水平没有差异(平均差异=1.33±8.70mmHg;p=.608)。与安慰剂相比,PC 摄入后 HR 平均值更高(平均差异=3.11±15.87bpm,p=.019,ηp2=.24),而最大 HR 在两种实验条件之间没有差异(p=.199)。这些发现表明,当需要降低 IOP 水平时(例如青光眼患者或有风险的患者),应避免在运动前摄入 PC。未来的研究应确定不同的运动补剂对不同运动模式和长期的 IOP 和 OPP 水平的影响。